Acne usually begins in puberty and affects many adolescents and young adults; however, it can occur at any stage of life and may continue into one’s 30s and 40s. (3-5) Adult acne continues to increase ...

Hold off on skincare until after you’ve applied the patch. Avoid using serums and heavy moisturizers under the pimple patch, ...

These products can dry your skin and make acne appear worse. Shampoo regularly. The oil from your hair can cause acne on your forehead. If you have oily hair, shampoo more often than you do now and ...

The event will feature key opinion leader (KOL) Neal Bhatia, MD (Director of Clinical Dermatology at Therapeutics Clinical Research in San Diego), who will join company management to review positive ...

Sagimet Biosciences to Host Virtual KOL Event, “A New Mechanism of Action in Treating Acne: Update on Positive Phase 3 Denifanstat Trial for the Treatment of Moderate to Severe Acne” on June ...

Jennifer Aniston has been using this under-$20 drying lotion since the '90s to shrink surprise breakouts fast — and it’s currently 15% off.

Oral FASN inhibitors offer a novel mechanism of action for the potential treatment of moderate to severe acne Sagimet initiated first-in-human Phase 1 clinical trial of a second FASN inhibitor, ...

At least one person died in rising floodwaters in Texas overnight, authorities said, as the Midwest and parts of the South were battered by storms, flooding and suspected tornadoes.

Shares of Sagimet Biosciences rose after the company disclosed what it called positive results from a recent clinical trial of its treatment for moderate-to-severe acne. The stock jumped 42%, to ...

Sagimet Biosciences Announces Positive Phase 3 Results for Denifanstat for the Treatment of Moderate-to-Severe Acne from Partner Ascletis. Jun. 04, 2025 5:00 AM ET Sagimet Biosciences Inc. ...

Potential Positives. Denifanstat met all primary and secondary endpoints in a Phase 3 clinical trial, demonstrating its efficacy for the treatment of moderate to severe acne vulgaris.

Denifanstat showed positive Phase 3 results in acne, meeting all goals with strong safety, as Sagimet pushes ahead with a second FASN inhibitor trial.